
Keywords: aPTT; Activated partial thromboplastin time; α2M-Thrombin; Alpha2 macroglobulin-thrombin; Anti-FXa; Anti-factor X activated; CAT; Calibrated automated thrombography; DVT; Deep venous thromboembolism; ETP; Endogenous thrombin potential; FVIII; Factor VI